271 related articles for article (PubMed ID: 25005249)
1. Superior rectus underaction following botulinum toxin injection to induce protective upper eye lid ptosis--a comparative study of two techniques.
Sadiq SA; Dharmasena A
Strabismus; 2014 Sep; 22(3):111-4. PubMed ID: 25005249
[TBL] [Abstract][Full Text] [Related]
2. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection.
Naik MN; Gangopadhyay N; Fernandes M; Murthy R; Honavar SG
Eye (Lond); 2008 Sep; 22(9):1132-6. PubMed ID: 17510652
[TBL] [Abstract][Full Text] [Related]
3. Abobotulinum toxin A (Dysport) and botulinum toxin type A (Botox) for purposeful induction of eyelid ptosis.
Reddy UP; Woodward JA
Ophthalmic Plast Reconstr Surg; 2010; 26(6):489-91. PubMed ID: 20724861
[TBL] [Abstract][Full Text] [Related]
4. A modified transconjunctival technique for botulinum toxin chemodenervation of levator palpebrae superioris for corneal protection.
Tint NL; Saxby EPI; Young SL; Alexander P
Eye (Lond); 2022 Jun; 36(6):1217-1221. PubMed ID: 34117397
[TBL] [Abstract][Full Text] [Related]
5. [Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A].
Nava Castañeda A; Tovilla Canales JL; Garnica Hayashi L; Velasco Y Levy A
J Fr Ophtalmol; 2017 Apr; 40(4):279-284. PubMed ID: 28336282
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin injection into the superior rectus for treatment of strabismus.
Dawson E; Ali N; Lee JP
Strabismus; 2012 Mar; 20(1):24-5. PubMed ID: 22390328
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin injection for postoperative diplopia testing in adult strabismus.
Khan J; Kumar I; Marsh IB
J AAPOS; 2008 Feb; 12(1):46-8. PubMed ID: 17964210
[TBL] [Abstract][Full Text] [Related]
8. Safe botulinum toxin type A injection in patients with history of eyelid ptosis.
Ghalamkarpour F; Aghazadeh Y; Odabaei G
J Cosmet Dermatol; 2009 Jun; 8(2):98-102. PubMed ID: 19527332
[TBL] [Abstract][Full Text] [Related]
9. Transcutaneous dysport injection for treatment of upper eyelid retraction associated with thyroid eye disease.
Salour H; Bagheri B; Aletaha M; Babsharif B; Kleshadi M; Abrishami M; Bagheri A
Orbit; 2010 Apr; 29(2):114-8. PubMed ID: 20394553
[TBL] [Abstract][Full Text] [Related]
10. Botulinum Toxin Injection for the Treatment of Strabismus: A Report by the American Academy of Ophthalmology.
Binenbaum G; Chang MY; Heidary G; Morrison DG; Trivedi RH; Galvin JA; Pineles SL
Ophthalmology; 2021 Dec; 128(12):1766-1776. PubMed ID: 34176652
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin-A-induced protective ptosis in the treatment of lagophthalmos associated with facial paralysis.
Yücel OE; Artürk N
Ophthalmic Plast Reconstr Surg; 2012; 28(4):256-60. PubMed ID: 22785583
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin injection with and without electromyographic assistance for treatment of abducens nerve palsy: a pilot study.
Sanjari MS; Falavarjani KG; Kashkouli MB; Aghai GH; Nojomi M; Rostami H
J AAPOS; 2008 Jun; 12(3):259-62. PubMed ID: 18396081
[TBL] [Abstract][Full Text] [Related]
13. A single transcutaneous injection with Botox for dysthyroid lid retraction.
Shih MJ; Liao SL; Lu HY
Eye (Lond); 2004 May; 18(5):466-9. PubMed ID: 15131675
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of botulinum toxin injection in patients with cerebral palsy and esotropia.
Ameri A; Mirmohammadsadeghi A; Makateb A; Bazvand F; Hosseini S
Strabismus; 2015; 23(1):8-13. PubMed ID: 25789846
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis.
Ellis MF; Daniell M
Clin Exp Ophthalmol; 2001 Dec; 29(6):394-9. PubMed ID: 11778810
[TBL] [Abstract][Full Text] [Related]
16. The role of botulinum toxin in correcting frontalis-induced eyelid pseudo-retraction post ptosis surgery.
Shome D; Jain V; Natarajan S
Indian J Ophthalmol; 2007; 55(4):307-8. PubMed ID: 17595485
[TBL] [Abstract][Full Text] [Related]
17. Distribution of the toxin following medial rectus muscular injection of botulinum toxin gel in rabbits.
Chen J; Mai G; Yu X; Yu H; Wu H; Lin X; Deng D; Kang Y
Yan Ke Xue Bao; 2005 Mar; 21(1):52-5. PubMed ID: 17162917
[TBL] [Abstract][Full Text] [Related]
18. A review of 5 years' experience in the use of botulinium toxin A in the treatment of sixth cranial nerve palsy at the Singapore National Eye Centre.
Quah BL; Ling YL; Cheong PY; Balakrishnan V
Singapore Med J; 1999 Jun; 40(6):405-9. PubMed ID: 10489509
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin injection of the inferior oblique muscle for the treatment of superior oblique muscle palsy.
Bagheri A; Eshaghi M
J AAPOS; 2006 Oct; 10(5):385-8. PubMed ID: 17070469
[TBL] [Abstract][Full Text] [Related]
20. The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles.
Bakheit AM; Fedorova NV; Skoromets AA; Timerbaeva SL; Bhakta BB; Coxon L
J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1558-61. PubMed ID: 15489387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
